Why do Funding and Legal Structure Matter in Decentralized Clinical Trials?
Optimizing clinical trial access for potential patients is a critical goal for researchers and sponsors. How can we make clinical
Optimizing clinical trial access for potential patients is a critical goal for researchers and sponsors. How can we make clinical
Discover how Advarra’s ICF writing services helped a site network create compliant, flexible processes, improving IRB submissions and timelines.
New to the process of helping to bring a drug to market? As intimidating as the Food and Drug Administration
Learn how DSMBs safeguard trial integrity and participant safety with insights on setup, member selection, and the importance of independence.
An incidental finding is a “finding” or result from an intervention or test that uncovers a condition or problem that
Learn the essentials of creating a robust charter for DMCs and EACs—an indispensable tool for clinical trial oversight and regulatory compliance.
To better understand when you may need an endpoint adjudication committee (EAC), it’s helpful to know the EAC’s role in research.
Explore the contributions of clinical trial superheroes, from coordinators to data analysts, improving patient health and outcomes.
In addition to other responsibilities, human subjects protection programs (HRPPs) and IRBs are tasked with ensuring a research protocol’s lifecycle
Over the past two years, Operation Warp Speed brought mRNA-based vaccines into the spotlight, as organizations like Moderna and Pfizer/BioNTech
Learn how organizations can expedite study startup and avoid delays through streamlining site selection, training, ethics review, and site initiation.
This blog outlines some of the critical events where endpoint adjudication committees (EACs) can be used to look at more than just “endpoints” in clinical research.